Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood-Based Biomarkers for Prediction and Monitoring of Response to TACE in Hepatocellular Carcinoma

NCT07414433 is registered in ClinicalTrials.gov with University of Belgrade as lead sponsor.

NCT NCT07414433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07414433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood-Based Biomarkers for Prediction and Monitoring of Response to TACE in Hepatocellular Carcinoma
Lead sponsor
University of Belgrade
Phase
Observational
Overall status
Not yet recruiting
Start date
March 1, 2026
Completion date
December 30, 2029
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma (hcc), liver neoplasms